ROSIE Woods first noticed that her son Louie was getting unexplained bruises on his body when he was just six months old.

Haemophilia patients in Haryana continue to suffer as life-saving medicines have not been available for months. Despite ...

Maharashtra haemophilia patients face medicine shortages, forcing travel to Gujarat for treatment, risking health and ...

Haemophilia, a rare blood disorder affecting clotting, is one such condition that can manifest early in life. It’s a ...

Despite a large portion of the Rs 91 crore budget remaining unspent, the State Health Coordinator has requested additional ...

An estimated 7700 people in England have haemophilia A, with around 1900 classified as severe cases where their factor VIII activity level is less than 1%. Current treatments involve factor VIII ...

Haemophilia is a rare genetic bleeding disorder that causes the blood to take a long time to clot because of a deficiency in one or several blood clotting factors. It is almost exclusively found ...

HIBISCUS phase 2 data evaluating the safety profile and efficacy of etavopivat in adult and adolescent patients with sickle cell disease FRONTIER4 interim phase 3 results evaluating safety profile and ...

The work of the CGT facility will span across multiple things - from boosting immune responses against cancer to ensuring ...

Pfizer will end the global commercialisation of its haemophilia gene therapy Beqvez (fidanacogene elaparvovec) amid low demand and interest. A Pfizer spokesperson told Pharmaceutical Technology in ...

Sobi’s Sanofi-partnered Altuvoct (efanesoctocog alfa) has been recommended by the National Institute for Health and Care Excellence (NICE) to treat and prevent bleeding in haemophilia A patients aged ...

In part one of the FRONTIER3 study, participants with haemophilia A received once-weekly doses of Mim8 administered under the skin for 26 weeks. In part two, participants had the option to ...